selected publications
-
academic article
- Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.. The Lancet. Respiratory medicine. 9:733-746. 2021
- Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. 2015
- Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use.. Chest. 145:695-703. 2014
- Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis.. The European respiratory journal. -. 2015